Literature DB >> 17126829

Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration.

Ruth McNamara1, Mark Maginn, Andrew Harkin.   

Abstract

Caffeine promotes hyperthermia and lethality when co-administered with the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") to rats. In the present study, co-administration of caffeine (10 mg/kg, s.c.) with MDMA (10 mg/kg, s.c.) induced a profound tachycardic response compared to rats treated with either drug alone. However, neither caffeine (30 microM) nor MDMA (1-30 microM), alone or in combination, affected the electrocardiogram of the isolated heart suggesting that central and sympathomimetic actions, rather than direct actions of these drugs on the heart, are responsible for the tachycardia observed in vivo. This is a serious drug interaction, which could have important health consequences for recreational drug users.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126829     DOI: 10.1016/j.ejphar.2006.10.063

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex.

Authors:  Giulia Costa; Nicola Simola; Micaela Morelli
Journal:  Psychopharmacology (Berl)       Date:  2014-04-01       Impact factor: 4.530

2.  Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy').

Authors:  Natacha Vanattou-Saïfoudine; Ruth McNamara; Andrew Harkin
Journal:  Psychopharmacology (Berl)       Date:  2010-05-02       Impact factor: 4.530

3.  Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats.

Authors:  N Vanattou-Saïfoudine; R McNamara; A Harkin
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 4.  Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators.

Authors:  N Vanattou-Saïfoudine; R McNamara; A Harkin
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 5.  Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?

Authors:  Noreen T Boyle; Thomas J Connor
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

6.  Influence of chronic caffeine on MDMA-induced behavioral and neuroinflammatory response in mice.

Authors:  Jessica Ruiz-Medina; Ana Pinto-Xavier; Marta Rodríguez-Arias; José Miñarro; Olga Valverde
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

7.  3,4-Methylenedioxymethamphetamine alters left ventricular function and activates nuclear factor-Kappa B (NF-κB) in a time and dose dependent manner.

Authors:  David A Tiangco; Sapna Halcomb; Frank A Lattanzio; Barbara Y Hargrave
Journal:  Int J Mol Sci       Date:  2010-11-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.